##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||Short Title|Full Priority Wording||
|---|---|---|---|
|||What strategies
can increase awareness
and understanding
ofDCM amongst||
||Raising Awareness|healthcare
professionals
and the public? Can these strategies
help improve||
|||timely diagnosis
and management
ofDCM?||
|2|Natural
History|What is the natural
history ofDCM? What is the relationship
between
DCM
asymptomatic
spinal cord compression
or canal stenosis'? What factors|and|
|||influence
the natural
history ofthe disease?||
||Diagnostic
Criteria|What is are the diagnostic
criteria ofDCM? What is the role of imaging
and
when should
imaging
be used in the assessment
ofDCM?||
|||What assessment
tools can be used to evaluate
functional
impairment,||
||Assessment
and|disability
and quality oflite in people with DCM? What instruments,
tools or||
||Monitoring|methods
can be used or developed to monitor people with DCM for disease||
|||progression
or improvement
either before or aRer surgical treatment?||
|5|Pathophysiology|What is the pathophysiology
ofDCM? What are the mechanisms
of
neurological
injury and the molecular
and anatomical
consequences'?||
|||What is the role of rehabilitation
following
surgery
for DCM? Can structured||
||Rehabilitation|postoperative
rehabilitation
improve
outcome
following
surgery
for DCM'? What||
|||are the most effective strategies?||
|1'|Novel Therapies|Can novel therapies,
including
stem-cell,
gene, pharmacological
and
neuroprotective
therapies,
improve the health
and wellbeing
ofpeople
liVing with||
|||DCM and slow down disease progression' ?||
||Socio-economic|What is the socio-economic
impact ofDCM? @hefinancial impact of living|with|
||Impact|OCM to the individual,
their supporters
and society as a whole)||
||Imaging Techniques|What is the role ofdynamic
or novel imaging techniques
and neurophysiology
the assessinent
ofDCM?|in|
|10|Individualising
Surgery|Are there clinical and imaging factors that can help a surgeon select who should
undergo
surgical decompression
in the setting of DCM? At what stage of the
disease is surgery the preferred
management
strategy?||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Restricted|Unrestricted|Total|Total|
|---|---|---|---|---|---|---|
||||funds|funds|funds|funds|
||||2021|2021|2021|2020|
|||Note||R|f.||
|Income from."|||||||
|Donations|||12,088|106,229|118,317|26,001|
|Charitable
activities||||4,946|4,946|7,727|
|investments||||21|21||
|Total income|||12,088|111,196|123,284|33,728|
|Expenditure
on:|||||||
|Raising funds||||1,842|1,842||
|Charitable
activities|||7,994|65,518|73,512|29,870|
|Total expenditure|||7,994|67,360|75,354|29,870|
|Net movement|in funds||4,094|435836|47,930|3,858|
|Reconciliation|offunds:||||||
|Total funds brought forward||||8,493|8,493|4,635|
|Net movement|in funds||4,094|43,836|47,930|3,858|
|Total funds carried forward|||4,094|52,329|56,423|8,493|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Unrestricted|Total|Total|
|---|---|---|
|funds|funds|funds|
|2021|2021|2020|
|R|||
|4,946|4,946|7,727|
##
|Unrestricted|Total|Total|
|---|---|---|
|funds|funds|funds|
|2021|2021|2020|
|R|||
|21|21||
##
|||||Unrestricted|Total|Total|
|---|---|---|---|---|---|---|
|||||funds|funds|funds|
|||||2021|2021|2020|
|Costs|ofraising|voluntary|income|1,842|1,842||
##
##
##
|||Activities||||
|---|---|---|---|---|---|
|||undertaken|Support|Total|Total|
|||directly|costs|funds|funds|
|||2021f|2021|2021|2020|
|Charitable|activities|5,964|67,548|73,512|29,870|
|Total 2020||8,424|21,446|29,870||
##
||Charitable|Total|Total|
|---|---|---|---|
||activities|funds|funds|
||2021|2021|2020|
|Education|3,095|3,095|3,559|
|Research|2,869|2,869|4,865|
||5,964|5,964|8,424|
##
|||Charitable|Total|Total|
|---|---|---|---|---|
|||activities|funds|funds|
|||2021|2021|2020|
|General office expenses||71|71|1,020|
|Computer
expenses||768|768|647|
|Insurance||398|398|248|
|Subscriptions||157|157|157|
|Travel and subsistence||||182|
|Grant funded|Google advertisements|50,519|50,519|18,632|
|Consultancy||14,375|14,375||
|Governance|costs|1,260|1,260|560|
|||67,548|67,548|21,446|
##
##
##
##
##
|||2021|2020|
|---|---|---|---|
|||R||
|Prepayments|and accrued income|149|f49|
|Tax recoverable||5,000|2,438|
|Grants receivable||2,088||
|||7,237|2,587|
##
|||2021|2020|
|---|---|---|---|
|Trade creditors||1,875||
|Accruals|and deferred income|3,200|750|
|||5,075|750|
##
##
##
##
##
##